MILESTONE SCIENTIFIC INC.
Close on Oct 19, 2026
- Market cap
- $31.01M
- P/E (TTM)
- –
- Dividend yield
- –
About Milestone Scientific
Orthopedic, Prosthetic & Surgical Appliances & Supplies, SIC 3842
Milestone Scientific Inc. develops and commercializes computer-controlled drug delivery systems designed to improve the safety, precision, and patient experience of subcutaneous injections and fluid aspiration procedures. Its core technology platform, Dynamic Pressure Sensing, regulates flow rates and monitors needle-tip pressure in real time. The company operates across dental and medical segments. In the dental sector, it offers instruments such as the CompuDent and STA Single Tooth Anesthesia systems alongside The Wand, a single-use disposable handpiece. In the medical market, the company provides the CompuFlo Epidural Computer Controlled Anesthesia System for epidural injections in lumbar and thoracic spinal regions.
The company distributes its dental products across the United States, Canada, and more than 40 other countries through distributor relationships and e-commerce channels. Its medical system holds regulatory clearances in the United States. Milestone Scientific maintains its principal executive offices in Roseland, New Jersey.
Summary of the business section of Milestone Scientific's latest annual report, written by StockData.
Company profile
Company
- Legal name
- MILESTONE SCIENTIFIC INC.
- Founded
- 1989
- Headquarters
- Livingston, NJ
- Address
- 220 South Orange Avenue 07039
- Phone
- (973) 535-2717
- Website
- milestonescientific.com
- Employees
- 15, Dec 31, 2025
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Marcum LLP, Morristown, New Jersey
Stock & identifiers
- Ticker
- MLSS
- Exchange
- NYSE
- IPO date
- Nov 3, 1995
- Shares outstanding
- 89M, Aug 11, 2026
- Public float
- $39.73M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-3 reverse, Jan 14, 2004
- SEC CIK
- 855683
- CUSIP
- 59935P209
- ISIN
- US59935P2092
- EIN
- 13-3545623
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Michael McGeehan | Director | 575,273 |
| Leonard Osser | Director | 9,055,580 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $795.02K | $77.02K | $496.91K | $29 | – |
| FY2024 | $881.42K | $881.42K | – | $137 | – |
| FY2024 Peo | $881.42K | – | – | $137 | – |
| FY2023 | $680.27K | $680.27K | – | $150 | – |
| FY2023 Peo | $680.27K | – | – | $150 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“of the most recent reporting period, the Company employed a total of 15 full-time employees.”
Corporate history
Events identified from SEC filings